Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001088147 | SCV000547477 | benign | Fanconi anemia | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000519850 | SCV000620201 | uncertain significance | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | Observed in an individual with seizures and developmental delay who was de novo for a variant in the SLC1A2 gene as well as compound heterozygous for the K458E variant and another SLX4 missense variant; however follow up testing for Fanconi anemia was normal (Guella et al., 2017); Identified in individuals with breast, ovarian, or head/neck cancers, but also observed in controls (Shah et al., 2013; Bakker et al. 2013; Chandrasekharappa et al., 2017; Rizzolo et al., 2019; Song et al., 2020); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23840564, 32546565, 28678401, 22911665, 30613976, 28777935) |
Fulgent Genetics, |
RCV000764064 | SCV000895018 | uncertain significance | Fanconi anemia complementation group P | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV003492056 | SCV001139916 | likely benign | Hereditary cancer | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000519850 | SCV001150772 | uncertain significance | not provided | 2017-12-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000764064 | SCV001280599 | uncertain significance | Fanconi anemia complementation group P | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Baylor Genetics | RCV000764064 | SCV001481709 | uncertain significance | Fanconi anemia complementation group P | 2019-06-19 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Institute for Clinical Genetics, |
RCV000519850 | SCV002010737 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001194850 | SCV002068071 | uncertain significance | not specified | 2020-01-13 | criteria provided, single submitter | clinical testing | DNA sequence analysis of the SLX4 gene demonstrated a sequence change, c.1372A>G, in exon 7 that results in an amino acid change, p.Lys458Glu. This sequence change has been previously described in a patient with breast cancer, however there is not enough evidence to support the pathogenicity of this sequence change in these studies (PMID: 22911665 and PMID: 23840564). This sequence change has been described in the gnomAD database with a low population frequency of 0.075% (dbSNP rs149126845). The p.Lys458Glu change affects a highly conserved amino acid residue located in a domain of the SLX4 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Lys458Glu substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Lys458Glu change remains unknown at this time. |
Sema4, |
RCV001088147 | SCV002529257 | likely benign | Fanconi anemia | 2021-04-07 | criteria provided, single submitter | curation | |
Leiden Open Variation Database | RCV001194850 | SCV001364681 | likely benign | not specified | 2012-08-31 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker. |